SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 10 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 3,500 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 3,500 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -41.7% | 3,500 | -36.4% | 0.00% | – |
| Q1 2022 | $12,000 | -52.0% | 5,500 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | -56.1% | 5,500 | -26.7% | 0.00% | – |
| Q3 2021 | $57,000 | -20.8% | 7,500 | 0.0% | 0.00% | – |
| Q2 2021 | $72,000 | +1.4% | 7,500 | -13.8% | 0.00% | – |
| Q1 2021 | $71,000 | +29.1% | 8,700 | +6.7% | 0.00% | – |
| Q4 2020 | $55,000 | +3.8% | 8,150 | +69.8% | 0.00% | – |
| Q3 2020 | $53,000 | +152.4% | 4,800 | +45.5% | 0.00% | – |
| Q2 2020 | $21,000 | +425.0% | 3,300 | +43.5% | 0.00% | – |
| Q1 2020 | $4,000 | -50.0% | 2,300 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +60.0% | 2,300 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |